Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Cholesterol Medication Recalls

Recalls of statins and other lipid-lowering drugs used to manage high cholesterol.

161 recalls in this category, newest first.

Class III · Low risk

Pravastatin Sodium Tablets

Failed Impurities/Degradation Specifications: high out of specification results for related impurity for lot C700220.

Terminated Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-229-90 D-1038-2017
Class II · Moderate risk

Atorvastatin Calcium Tablets

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Terminated Microbial contamination Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-208-20 D-0622-2017
Class II · Moderate risk

Atorvastatin Calcium Tablets

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Terminated Microbial contamination Mylan Pharmaceuticals Inc. NDC 0378-3953-09 D-0621-2017
Class II · Moderate risk

Atorvastatin Calcium Tablets

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Terminated Microbial contamination Mylan Pharmaceuticals Inc. NDC 0378-3952-09 D-0620-2017
Class II · Moderate risk

Atorvastatin Calcium Tablets

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Terminated Microbial contamination Mylan Pharmaceuticals Inc. NDC 0378-3951-09 D-0619-2017
Class II · Moderate risk

Atorvastatin Calcium Tablets

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Terminated Microbial contamination Mylan Pharmaceuticals Inc. NDC 0378-3950-77 D-0618-2017
Class III · Low risk

Fenofibrate Capsules

Labeling: Incorrect or Missing Lot and/or Exp Date

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-835-32 D-0823-2016
Class III · Low risk

Fenofibrate Capsules

Labeling: Incorrect or Missing Lot and/or Exp Date

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-835-32 D-0822-2016
Class III · Low risk

Fenofibrate Capsules

Labeling: Incorrect or Missing Lot and/or Exp. Date

Terminated Labeling / mix-up Impax Laboratories, Inc. NDC 0115-0533-02 D-0821-2016
Class III · Low risk

Fenofibrate Capsules

Labeling: Incorrect or Missing Lot and/or Exp. Date

Terminated Labeling / mix-up Impax Laboratories, Inc. NDC 0115-0522-02 D-0820-2016
Class II · Moderate risk

Fenoglide (fenofibrate)

Failed Dissolution Specifications: Failed 24 month dissolution testing.

Terminated Dissolution failure Valeant Pharmaceuticals North America LLC D-0163-2016